Chorioretinal Scar
Understanding Chorioretinal Scar (Retinal Scar, Macular Scar) diagnosis, clinical documentation, and medical coding? Find information on Chorioretinal Scar symptoms, treatment, and ICD-10 codes for accurate healthcare records. Learn about retinal scar management and best practices for medical professionals documenting Chorioretinal Scar in patient charts. This resource offers guidance on macular scar terminology for improved clinical communication and proper medical coding.
Permanent retinal damage causing a visible scar, often from inflammation or injury.
Blurred vision, distorted vision, or a blind spot in central vision.
Ophthalmology clinics, retina specialist consultations, low vision rehabilitation.
ICD-10 Code Families
Complete code families applicable to H31.009
When to use each related code
| Description | When to use |
|---|---|
| Scar tissue on the retina. | Use for healed chorioretinal inflammation. Consider laterality (e.g., right eye, left eye). |
| Retinal damage from diabetes. | Diabetic retinopathy with visible scarring or macular edema. Specify stage if known (e.g., NPDR, PDR). |
| Age-related macular scarring. | Scarring due to age-related macular degeneration (AMD). Specify wet or dry AMD. |
Best-practice checklist
- ✓Document scar location (e.g., macula, periphery)
- ✓Document scar size (e.g., disc diameters, mm)
- ✓Describe scar characteristics (e.g., pigmented, elevated)
- ✓Document any associated visual symptoms
- ✓ICD-10 code H35.852 for Chorioretinal scar
Common pitfalls to avoid
Coding requires specifying right, left, or bilateral eye involvement. Missing laterality can lead to claim denials and inaccurate data.
Documenting the underlying etiology (e.g., toxoplasmosis, macular degeneration) is crucial for accurate coding and avoiding rejected claims.
Favor specific scar types (e.g., macular scar) over the general 'chorioretinal scar' if clinically supported, for improved data quality and reimbursement.
Best-practice tips
- 01ICD-10 H35.83 accurate coding for chorioretinal scar documentation.
- 02SNOMED CT 399724001: CDI compliant retinal scar clinical notes.
- 03Timely dilated eye exams improve macular scar diagnosis and treatment.
- 04OCT imaging essential for chorioretinal scar size, depth documentation.
- 05Anti-VEGF therapy for subretinal neovascularization reduces scar growth.
Step-by-step checklist
- 1
Confirm scar location (chorioretinal, macular, peripheral)
- 2
Document scar morphology (size, shape, pigmentation)
- 3
Evaluate for underlying cause (e.g., infection, inflammation)
- 4
Assess visual acuity and impact on function
- 5
Rule out active inflammation or neovascularization
Ready-to-paste narrative
Patient presents with complaints consistent with chorioretinal scar. Visual acuity assessment revealed [insert specific visual acuity measurements for each eye, e.g., 20/40 OD, 20/30 OS]. Funduscopic examination demonstrated a well-demarcated chorioretinal scar in the [right eye, left eye, or both eyes; specify location, e.g., macular, peripheral] characterized by [describe appearance, e.g., pigmented, depigmented, flat, elevated]. The scar measures approximately [size in disc diameters or millimeters]. Patient history includes [mention any relevant history such as previous ocular inflammation, trauma, laser treatment, infection, or systemic diseases like toxoplasmosis or histoplasmosis]. Differential diagnosis considered included macular degeneration, choroidal nevus, and other retinal pigment epithelial abnormalities. Based on clinical findings, the diagnosis of chorioretinal scar is confirmed. Current symptoms include [list symptoms such as blurred vision, metamorphopsia, scotoma, or if asymptomatic]. No active inflammation is observed. Plan of care includes monitoring visual acuity, Amsler grid testing for metamorphopsia, and patient education regarding the generally stable nature of chorioretinal scars. Low vision rehabilitation will be considered if significant vision impairment is present. ICD-10 code H35.83 (Other retinal disorders) is considered for medical billing and coding purposes, although more specific coding may be appropriate depending on the underlying etiology if known. Return visit scheduled in [timeframe] for follow-up.
Common questions and answers
What are the key differential diagnoses to consider when evaluating a patient with a suspected chorioretinal scar, and how can I differentiate between them using multimodal imaging?+
When encountering a suspected chorioretinal scar, several other conditions can mimic its appearance, requiring careful differentiation. These include choroidal nevus, retinal pigment epithelial (RPE) hyperplasia, and old choroidal hemorrhage. Multimodal imaging plays a crucial role in distinguishing these entities. For instance, optical coherence tomography (OCT) can help assess the retinal layers and identify any associated RPE changes or subretinal fluid, aiding in differentiating a scar from a nevus or RPE hyperplasia. Fundus autofluorescence (FAF) can reveal characteristic hypoautofluorescence in chorioretinal scars due to RPE atrophy. Indocyanine green angiography (ICGA) can further characterize the choroidal vasculature and identify any abnormalities associated with the scar. Integrating findings from these imaging modalities helps arrive at a more accurate diagnosis. Consider implementing a standardized imaging protocol for evaluating suspected chorioretinal scars to improve diagnostic accuracy. Explore how multimodal imaging can be incorporated into your practice for improved patient management.
How does the management of a chorioretinal scar near the fovea differ from the management of a peripheral chorioretinal scar, particularly in terms of monitoring and potential interventions?+
The location of a chorioretinal scar significantly influences its management. While peripheral chorioretinal scars are often asymptomatic and require minimal intervention beyond routine monitoring for stability, scars located near the fovea can cause significant visual impairment due to their proximity to the macula. In such cases, regular monitoring with OCT and visual field testing is crucial to detect any changes in macular thickness or visual function. If the scar is associated with choroidal neovascularization (CNV), treatment with anti-VEGF injections may be necessary to prevent further vision loss. Furthermore, patients with juxtafoveal scars should be educated about the potential risks of CNV development and the importance of regular follow-up. Learn more about the latest guidelines for managing chorioretinal scars and explore the role of anti-VEGF therapy in preserving vision.
What are the potential long-term complications of a chorioretinal scar, such as choroidal neovascularization (CNV) or macular edema, and what preventative strategies or early interventions can mitigate these risks?+
Chorioretinal scars, while often stable, can be associated with long-term complications such as choroidal neovascularization (CNV) or macular edema, particularly when located near the macula. These complications can lead to significant vision loss if not managed promptly. Regular monitoring with OCT and Amsler grid testing can help detect early signs of CNV or macular edema. Preventative strategies, such as controlling systemic risk factors like hypertension and hyperlipidemia, may play a role in reducing the risk of CNV. If CNV develops, prompt treatment with anti-VEGF injections is crucial to prevent further vision loss. For macular edema associated with the scar, treatment options may include corticosteroids or anti-VEGF therapy. Explore the current research on the risk factors and pathogenesis of CNV in chorioretinal scars to better understand and manage these complications.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.